From: Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer
Variable |  | Up (n = 15) | Down (n = 5) |  |
---|---|---|---|---|
N or mean (std) | N or mean (std) | p value | ||
Age | Years | 57.1 (7.2) | 59.2 (9.9) | 0.62 |
Gender | Male | 12 | 2 | 0.27 |
Female | 3 | 3 | Â | |
Clinical stage | 2 | 1 | - | 1.00 |
3 | 2 | 1 | Â | |
4 | 12 | 4 | Â | |
T stage | T1 | 2 | 1 | 0.67 |
T2 | 8 | 1 | Â | |
T3 | 2 | 2 | Â | |
T4 | 3 | 1 | Â | |
N stage | N0 | 1 | 2 | 0.17 |
N1 | 3 | 0 | Â | |
N2 | 11 | 3 | Â | |
Disease site | Larynx | 1 | 1 | 0.25 |
Oral cavity | 2 | - | Â | |
Oropharynx | 12 | 3 | Â | |
Nasopharynx | 0 | 1 | Â | |
Treatment | Chemotherapy | 0 | 1 | 0.15 |
Surgery | 3 | - | Â | |
Chemoradiotherapy | 12 | 4 | Â | |
ACE comorbidities score | None | 5 | 1 | 0.36 |
Mild | 8 | 3 | Â | |
Moderate | 2 | - | Â | |
Severe | 0 | 1 | Â | |
BMI | Normal (15.5–24.9) | 2 | - | 0.84 |
Overweight (25–29.9) | 6 | 3 |  | |
Obese (30 +) | 7 | 2 |  | |
HPV status | Negative | 3 | 3 | 0.25 |
Positive | 12 | 2 | Â | |
Drinker | Never | 1 | - | 1.00 |
Current | 13 | 4 | Â | |
Former (quit > 12 months) | 1 | 1 |  | |
Smoker (cigarettes) | Never | 5 | - | 0.04 |
Current | 7 | 1 | Â | |
Former (quit > 12 months) | 3 | 4 |  |